ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,204.89
0.21%
Dow Jones
40,665.02
-1.29%
Gold vs US Dollar
2,423.11
-0.90%
Brent Oil
83.835
-0.29%
Bitcoin
64,133.77
0.25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Apellis Pharmaceuticals Inc (APLS) Share Price

APLS Apellis Pharmaceuticals Inc

37.95
-1.54 (-3.90%)
18 Jul 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Apellis Pharmaceuticals Inc NASDAQ:APLS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -1.54 -3.90 37.95 37.95 38.09 39.84 36.56 39.78 1,488,631 22:56:29   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 396.59M -525.63M -4.3309 -8.77 4.79B
 Type  Size  Price  Time  Units 
 9 1 38.09 21:20:59 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore APLS News
19/07/202400:39PRNUSKuehn Law Encourages Investors of Apellis Pharmaceuticals, Inc. to Contact Law Firm
18/07/202412:00GLOBEApellis Pharmaceuticals to Host Conference Call on August 1, 2024, to Discuss Second Quarter 2024 Financial Results
09/07/202412:00GLOBEApellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting
28/06/202411:57GLOBEApellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
10/06/202412:00GLOBESYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)
05/06/202421:50EDGAR2Form 8-K - Current report
05/06/202412:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
Period
Draw mode
Data Downloads for APLS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Apellis Pharmaceuticals Inc Articles